scispace - formally typeset
D

David Forman

Researcher at International Agency for Research on Cancer

Publications -  310
Citations -  151035

David Forman is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 95, co-authored 310 publications receiving 142982 citations. Previous affiliations of David Forman include Cancer Epidemiology Unit & Medical Research Council.

Papers
More filters
Journal Article

Variability in serum pepsinogen levels in an asymptomatic population

TL;DR: Serum pepsinogen A and C levels were significantly higher in the 33.6% of participants who were seropositive, but causes of gastritis other than H. pylori were indicated.
Journal ArticleDOI

Changes in and predictors of length of stay in hospital after surgery for breast cancer between 1997/98 and 2004/05 in two regions of England: a population-based study

TL;DR: The number of days spent in hospital after breast cancer surgery has continued to decline for several decades, and the change from mastectomy to BCS accounts for only 9% of the overall decrease in LOS.
Journal ArticleDOI

Methylene Tetrahydrofolate Reductase Genotype Modifies the Chemopreventive Effect of Folate in Colorectal Adenoma, but not Colorectal Cancer

TL;DR: It is suggested that dietary folate intake may be an important determinant for premalignant colorectal disease development but not coloreCTal cancer, an association that is modified by MTHFR genotype.
Journal ArticleDOI

Comparison of treatment and outcome information between a clinical trial and the National Cancer Data Repository

TL;DR: This study compared treatment and outcome information between the Medical Research Council Conventional versus Laparoscopic‐Assisted Surgery in Colorectal Cancer (CLASICC) trial and the National Cancer Data Repository (NCDR).
Journal ArticleDOI

The long term survival of rectal cancer patients following abdominoperineal and anterior resection: results of a population-based observational study.

TL;DR: Evidence suggests that the outcomes of the two main surgical procedures used in curative surgery for rectal cancer are different and that, when possible, AR should be the operation of choice.